Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
22 hedge funds and large institutions have $5.67M invested in Orgenesis Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 13 reducing their positions, and 5 closing their positions.
14% more capital invested
Capital invested by funds: $4.99M → $5.67M (+$675K)
15% less funds holding
Funds holding: 26 → 22 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
92% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 13
99% less call options, than puts
Call options by funds: $1K | Put options by funds: $73K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$59.3K |
| 2 |
State Street
Boston,
Massachusetts
|
+$18.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$62K |
| 2 |
VF
Virtu Financial
New York
|
-$60.1K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$55.5K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$42K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$36K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| – | -$1.37K | -45 | -78% |
|
ORGS Hedge Fund Activity: Q1 2022 in Review
22 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q1 2022, worth a combined $5.67M — up 14% from $4.99M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ORGS and 1 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 1 added.
The largest buyer was Kennedy Capital Management, opening a new position worth an estimated $59.3K. The largest seller was Acadian Asset Management, exiting entirely with an estimated $62K sold.
- 22 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q1 2022, down from 26 in Q4 2021.
- Funds reported $5.67M of Orgenesis Inc. Common Stock stock for Q1 2022, up 14% quarter-over-quarter.
- 1 fund opened new Orgenesis Inc. Common Stock positions in Q1 2022 and 5 closed out, a net change of -4 holders.
- The largest Orgenesis Inc. Common Stock buyer in Q1 2022 was Kennedy Capital Management, an estimated $59.3K added.
- The largest Orgenesis Inc. Common Stock seller in Q1 2022 was Acadian Asset Management, an estimated $62K sold.
Based on aggregated 13F filings for Q1 2022.